AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Actemra 162mg Prefilled Syringe

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Tocilizumab (162mg)

Overview Actemra 162mg Prefilled Syringe

RoActemra (tocilizumab) 162mg pre-filled syringe treats diverse inflammatory disorders affecting joints (rheumatoid, psoriatic arthritis, ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis, Crohn's disease). Its mechanism involves TNF-alpha inhibition, reducing inflammation. Administration is solely by a healthcare provider; self-injection is strictly prohibited. Consistent, daily dosing maximizes efficacy; adhere to your physician's prescribed regimen, completing the course even with symptom improvement. Common adverse events include headache, hypertension, upper respiratory infections, elevated liver enzymes, and nasopharyngitis. Report persistent or bothersome side effects to your doctor; management strategies exist. Increased infection susceptibility is a possibility. Immediately report infection signs (fever, cough, rash, diarrhea, influenza-like symptoms). Prior to treatment, disclose any heart, kidney, or liver issues, and all concurrent medications. Regular blood tests monitor potential effects on blood cell counts. Pregnant or breastfeeding individuals should consult their physician before commencing treatment.

Uses of Actemra 162mg Prefilled Syringe

Managing ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease.

Major Benefits of Actemra 162mg Prefilled Syringe:

Healthcare professionals will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

Common Side effects of Actemra 162mg Prefilled Syringe:

  • Headache
  • High blood pressure
  • Upper respiratory tract infection
  • Injection site reactions (pain, swelling, redness)

How to use Actemra 162mg Prefilled Syringe:

A healthcare professional will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

How Actemra 162mg Prefilled Syringe works:

Tocilizumab (Actemra 162mg) injection neutralizes specific inflammatory mediators, thereby alleviating the swelling, redness, and inflammation characteristic of some arthritic conditions.

SAFETY ADVICE

AlcoholAlcoholSAFE

Actemra 162mg Prefilled Syringe use alongside alcohol consumption presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Tocilizumab 162mg prefilled syringes may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Tocilizumab 162mg pre-filled syringe (brand name Actemra) is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Tocilizumab 162mg pre-filled syringes can induce drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.

KidneyKidneyCAUTION

Tocilizumab 162mg prefilled syringe requires careful administration in individuals with impaired renal function. Dosage modification of the 162mg prefilled tocilizumab syringe may be necessary. Physician consultation is recommended. Data regarding the use of the 162mg tocilizumab prefilled syringe in patients exhibiting moderate to severe kidney disease is limited. No dosage change is warranted for patients with mild kidney impairment.

LiverLiverCAUTION

Tocilizumab 162mg prefilled syringes require careful administration in individuals with hepatic impairment. Dosage modification of the 162mg prefilled syringe may be necessary. Physician consultation is advised. The 162mg tocilizumab prefilled syringe is contraindicated in patients exhibiting active liver disease.

What if you forget to take Actemra 162mg Prefilled Syringe :

Should you forget a scheduled Actemra 162mg pre-filled syringe injection, seek your physician's advice.

Facts to Know About Actemra 162mg Prefilled Syringe

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Therapeutics
Actions Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs)

FAQs on Actemra 162mg Prefilled Syringe

Actemra 162mg Prefilled Syringe is indicated for treating moderate to severe Covid-19 patients with persistent, worsening hypoxia despite 24-48 hours of corticosteroid and supportive care.
Actemra 162mg Prefilled Syringe isn't suitable for all COVID-19 patients due to potential risks. It may prolong infection and viral shedding, necessitating careful consideration where benefits clearly surpass potential harm.
Actemra 162mg Prefilled Syringe may cause serious side effects, including anaphylaxis during infusion, elevated liver enzymes (transaminitis), low white blood cell counts (leukopenia and neutropenia, increasing infection risk), and serious bacterial, viral, or reactivated tuberculosis infections.
Actemra 162mg Prefilled Syringe is contraindicated in patients with abnormal liver enzyme levels (transaminitis), low platelet counts (<50,000), tuberculosis, or any active bacterial or viral infection. Its use is also contraindicated during pregnancy and breastfeeding due to the risk of serious complications.
If your condition doesn't improve after using Actemra 162mg Prefilled Syringe, your doctor will determine the next steps. Actemra reduces lung inflammation but doesn't repair pre-existing damage; lung recovery takes time. Continued shortness of breath warrants further investigation for potential pulmonary (like intravascular coagulopathy) or cardiac issues. Any concurrent bacterial infections require separate treatment.
Actemra 162mg Prefilled S...
95,321